United States Apixaban Market Report 2016

United States Apixaban Market Report 2016

1 Apixaban Overview

1.1 Product Overview and Scope of Apixaban

1.2 Classification of Apixaban

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Apixaban

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Apixaban (2011-2021)

1.4.1 United States Apixaban Sales and Growth Rate (2011-2021)

1.4.2 United States Apixaban Revenue and Growth Rate (2011-2021)

2 United States Apixaban Competition by Manufacturers

2.1 United States Apixaban Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Apixaban Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Apixaban Average Price by Manufactures (2015 and 2016)

2.4 Apixaban Market Competitive Situation and Trends

2.4.1 Apixaban Market Concentration Rate

2.4.2 Apixaban Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Apixaban Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Apixaban Sales and Market Share by Type (2011-2016)

3.2 United States Apixaban Revenue and Market Share by Type (2011-2016)

3.3 United States Apixaban Price by Type (2011-2016)

3.4 United States Apixaban Sales Growth Rate by Type (2011-2016)

4 United States Apixaban Sales (Volume) by Application (2011-2016)

4.1 United States Apixaban Sales and Market Share by Application (2011-2016)

4.2 United States Apixaban Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Apixaban Manufacturers Profiles/Analysis

5.1 Pfizer, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Apixaban Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer Healthcare AG (Germany)

5.2.2 Apixaban Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 GlaxoSmithKline Plc. (UK)

5.3.2 Apixaban Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Boehringer Ingelheim (Germany)

5.4.2 Apixaban Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi S.A. (France)

5.5.2 Apixaban Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Abbott India Limited (India)

5.6.2 Apixaban Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Aspen Holdings (South Africa)

5.7.2 Apixaban Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bristol-Myers Squibb Company (US)

5.8.2 Apixaban Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Eisai Inc. (US)

5.9.2 Apixaban Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Mitsubishi Tanabe Pharma Corporation (Japan)

5.10.2 Apixaban Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 Apixaban Manufacturing Cost Analysis

6.1 Apixaban Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Apixaban

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Apixaban Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Apixaban Market Forecast (2016-2021)

10.1 United States Apixaban Sales, Revenue Forecast (2016-2021)

10.2 United States Apixaban Sales Forecast by Type (2016-2021)

10.3 United States Apixaban Sales Forecast by Application (2016-2021)

10.4 Apixaban Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Apixaban

Table Classification of Apixaban

Figure United States Sales Market Share of Apixaban by Type in 2015

Table Application of Apixaban

Figure United States Sales Market Share of Apixaban by Application in 2015

Figure United States Apixaban Sales and Growth Rate (2011-2021)

Figure United States Apixaban Revenue and Growth Rate (2011-2021)

Table United States Apixaban Sales of Key Manufacturers (2015 and 2016)

Table United States Apixaban Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Apixaban Sales Share by Manufacturers

Figure 2016 Apixaban Sales Share by Manufacturers

Table United States Apixaban Revenue by Manufacturers (2015 and 2016)

Table United States Apixaban Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Apixaban Revenue Share by Manufacturers

Table 2016 United States Apixaban Revenue Share by Manufacturers

Table United States Market Apixaban Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Apixaban Average Price of Key Manufacturers in 2015

Figure Apixaban Market Share of Top 3 Manufacturers

Figure Apixaban Market Share of Top 5 Manufacturers

Table United States Apixaban Sales by Type (2011-2016)

Table United States Apixaban Sales Share by Type (2011-2016)

Figure United States Apixaban Sales Market Share by Type in 2015

Table United States Apixaban Revenue and Market Share by Type (2011-2016)

Table United States Apixaban Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Apixaban by Type (2011-2016)

Table United States Apixaban Price by Type (2011-2016)

Figure United States Apixaban Sales Growth Rate by Type (2011-2016)

Table United States Apixaban Sales by Application (2011-2016)

Table United States Apixaban Sales Market Share by Application (2011-2016)

Figure United States Apixaban Sales Market Share by Application in 2015

Table United States Apixaban Sales Growth Rate by Application (2011-2016)

Figure United States Apixaban Sales Growth Rate by Application (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Apixaban Sales Market Share (2011-2016)

Table Bayer Healthcare AG (Germany) Basic Information List

Table Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Healthcare AG (Germany) Apixaban Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc. (UK) Basic Information List

Table GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc. (UK) Apixaban Sales Market Share (2011-2016)

Table Boehringer Ingelheim (Germany) Basic Information List

Table Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim (Germany) Apixaban Sales Market Share (2011-2016)

Table Sanofi S.A. (France) Basic Information List

Table Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A. (France) Apixaban Sales Market Share (2011-2016)

Table Abbott India Limited (India) Basic Information List

Table Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott India Limited (India) Apixaban Sales Market Share (2011-2016)

Table Aspen Holdings (South Africa) Basic Information List

Table Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Aspen Holdings (South Africa) Apixaban Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Company (US) Basic Information List

Table Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Company (US) Apixaban Sales Market Share (2011-2016)

Table Eisai Inc. (US) Basic Information List

Table Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Inc. (US) Apixaban Sales Market Share (2011-2016)

Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List

Table Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales Market Share (2011-2016)

Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List

Table Teva Pharmaceutical Industries Ltd. (Israel) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceutical Industries Ltd. (Israel) Apixaban Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Apixaban

Figure Manufacturing Process Analysis of Apixaban

Figure Apixaban Industrial Chain Analysis

Table Raw Materials Sources of Apixaban Major Manufacturers in 2015

Table Major Buyers of Apixaban

Table Distributors/Traders List

Figure United States Apixaban Production and Growth Rate Forecast (2016-2021)

Figure United States Apixaban Revenue and Growth Rate Forecast (2016-2021)

Table United States Apixaban Production Forecast by Type (2016-2021)

Table United States Apixaban Consumption Forecast by Application (2016-2021)